Annexin Pharmaceuticals announces important progress in the company’s preclinical cancer research where the drug candidate ANXV has shown promising results as a transporter of chemotherapy drugs to kill cancer cells.
Annexin Pharmaceuticals announces important progress in the company’s preclinical cancer research where the drug candidate ANXV has shown promising results as a transporter of chemotherapy drugs to kill cancer cells.